Martin Auinger

2.1k total citations
53 papers, 1.6k citations indexed

About

Martin Auinger is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Martin Auinger has authored 53 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Surgery and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Martin Auinger's work include Diabetes Treatment and Management (10 papers), Lipoproteins and Cardiovascular Health (7 papers) and Respiratory Support and Mechanisms (6 papers). Martin Auinger is often cited by papers focused on Diabetes Treatment and Management (10 papers), Lipoproteins and Cardiovascular Health (7 papers) and Respiratory Support and Mechanisms (6 papers). Martin Auinger collaborates with scholars based in Austria, United States and Germany. Martin Auinger's co-authors include K Irsigler, Florian Kronenberg, Hans Dieplinger, Karl Lhotta, Thomas Kästenbauer, Ulrich Neyer, Hartmut Zwick, D. Formanek, Paul König and T. Wanke and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Martin Auinger

52 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Auinger Austria 22 548 441 382 336 285 53 1.6k
Sergio De Marchi Italy 19 299 0.5× 194 0.4× 163 0.4× 297 0.9× 103 0.4× 54 1.2k
Jan Dirk Banga Netherlands 22 577 1.1× 247 0.6× 159 0.4× 924 2.8× 208 0.7× 35 2.0k
Mari-Anne Gall Denmark 17 304 0.6× 797 1.8× 667 1.7× 725 2.2× 174 0.6× 26 2.1k
Armando Lindner United States 13 506 0.9× 270 0.6× 875 2.3× 530 1.6× 189 0.7× 17 1.9k
Ki Ryang Na South Korea 22 325 0.6× 237 0.5× 708 1.9× 232 0.7× 173 0.6× 110 1.6k
S Sulková Czechia 21 301 0.5× 193 0.4× 783 2.0× 140 0.4× 221 0.8× 95 1.7k
Patrizia Pizzini Italy 22 239 0.4× 454 1.0× 725 1.9× 299 0.9× 264 0.9× 58 1.7k
Ken Okubo Japan 15 176 0.3× 200 0.5× 307 0.8× 456 1.4× 159 0.6× 20 1.3k
Mohsen Agharazii Canada 30 484 0.9× 259 0.6× 797 2.1× 952 2.8× 154 0.5× 114 2.5k
Per‐Ola Attman Sweden 21 462 0.8× 382 0.9× 518 1.4× 199 0.6× 104 0.4× 44 1.3k

Countries citing papers authored by Martin Auinger

Since Specialization
Citations

This map shows the geographic impact of Martin Auinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Auinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Auinger more than expected).

Fields of papers citing papers by Martin Auinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Auinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Auinger. The network helps show where Martin Auinger may publish in the future.

Co-authorship network of co-authors of Martin Auinger

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Auinger. A scholar is included among the top collaborators of Martin Auinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Auinger. Martin Auinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Königsbrügge, Oliver, Sabine Schmaldienst, Martin Auinger, et al.. (2020). Antithrombotic agents for primary and secondary prevention of cardiovascular events in patients with end-stage renal disease on chronic hemodialysis. Atherosclerosis. 298. 1–6. 8 indexed citations
2.
Sourij, Harald, Friedrich C. Prischl, Martin Auinger, et al.. (2019). Diabetische Nierenerkrankung (Update 2019). Wiener klinische Wochenschrift. 131(S1). 151–163. 2 indexed citations
3.
4.
5.
Prischl, Friedrich C., Martin Auinger, Marcus D. Säemann, et al.. (2015). Diabetes-related end-stage renal disease in Austria 1965–2013. Nephrology Dialysis Transplantation. 30(11). 1920–1927. 21 indexed citations
6.
Auinger, Martin, Friedrich C. Prischl, Alexandra Kautzky‐Willer, et al.. (2012). Diabetische Nephropathie – Update 2012. Wiener klinische Wochenschrift. 124(S2). 42–49. 4 indexed citations
7.
Hochegger, Kathrin, Michael Rudnicki, Martin Auinger, et al.. (2009). Fever of unknown origin in renal transplant patients with tacrolimus. Clinical Transplantation. 23(4). 575–579. 5 indexed citations
8.
Stadler, Marietta, Christian Anderwald, Martin Auinger, et al.. (2009). Persistent arterial stiffness and endothelial dysfunction following successful pancreas–kidney transplantation in Type 1 diabetes. Diabetic Medicine. 26(10). 1010–1018. 14 indexed citations
9.
Haider, Dominik G., Josef Kovařík, Susanne Heiss, et al.. (2008). Postprandial intradialytic dysglycaemia and diabetes in maintenance haemodialysis patients. European Journal of Clinical Investigation. 38(10). 721–727. 2 indexed citations
10.
Kotanko, Peter, Reinhard Kramar, Eduard Paschke, et al.. (2004). Results of a Nationwide Screening for Anderson-Fabry Disease among Dialysis Patients. Journal of the American Society of Nephrology. 15(5). 1323–1329. 150 indexed citations
11.
Kronenberg, Florian, Arno Lingenhel, Ulrich Neyer, et al.. (2003). Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients. Kidney International. 63(84). S113–S116. 71 indexed citations
12.
Kästenbauer, Thomas, S Sauseng, Gerald H. Sokol, Martin Auinger, & K Irsigler. (2001). A Prospective Study of Predictors for Foot Ulceration in Type 2 Diabetes. Journal of the American Podiatric Medical Association. 91(7). 343–350. 62 indexed citations
13.
Haas, Martin, Alice Schmidt, U Neyer, et al.. (1998). Angiotensin-Converting Enzyme Gene Polymorphism Determines the Antiproteinuric and Systemic Hemodynamic Effect of Enalapril in Patients with Proteinuric Renal Disease. Kidney & Blood Pressure Research. 21(1). 66–69. 50 indexed citations
14.
Vychytil, Andreas, Manuela Födinger, Gabriele Wölfl, et al.. (1998). Major determinants of hyperhomocysteinemia in peritoneal dialysis patients. Kidney International. 53(6). 1775–1782. 65 indexed citations
15.
Auinger, Martin, et al.. (1997). Normocalcaemic hepatorenal sarcoidosis with crescentic glomerulonephritis. Nephrology Dialysis Transplantation. 12(7). 1474–1477. 9 indexed citations
16.
Kästenbauer, Thomas, Martin Auinger, & K Irsigler. (1994). [Prevalence of cardiac autonomic neuropathies in uremia and diabetes mellitus].. PubMed. 106(23). 733–7. 4 indexed citations
17.
Wanke, T., Wolfgang Grisold, D. Formanek, et al.. (1992). Phrenic Nerve Function in Type 1 Diabetic Patients with Diaphragm Weakness and Peripheral Neuropathy. Respiration. 59(4). 233–237. 28 indexed citations
18.
Wanke, T., D. Formanek, Martin Auinger, et al.. (1992). Mechanical load on the inspiratory muscles during exercise hyperpnea in patients with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 35(5). 425–428. 2 indexed citations
19.
Formanek, D., et al.. (1992). Pulmonary Gas Exchange and Oxygen Uptake During Exercise in Patients with Type 1 Diabetes Mellitus. Diabetic Medicine. 9(3). 252–257. 31 indexed citations
20.
Wanke, T., D. Formanek, Martin Auinger, et al.. (1991). Inspiratory Muscle Performance and Pulmonary Function Changes in Insulin-dependent Diabetes Mellitus. American Review of Respiratory Disease. 143(1). 97–100. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sergio De Marchi Breakdown of academic impact, for papers by Jan Dirk Banga Breakdown of academic impact, for papers by Mari-Anne Gall Breakdown of academic impact, for papers by Armando Lindner Breakdown of academic impact, for papers by Ki Ryang Na Breakdown of academic impact, for papers by S Sulková Breakdown of academic impact, for papers by Patrizia Pizzini Breakdown of academic impact, for papers by Ken Okubo Breakdown of academic impact, for papers by Mohsen Agharazii Breakdown of academic impact, for papers by Per‐Ola Attman
Rankless by CCL
2026